Allergic Conjunctivitis (AC) - Epidemiology Forecast to 2028

DelveInsight’s ‘Allergic Conjunctivitis (AC) - Epidemiology Forecast to 2028’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Allergic Conjunctivitis in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.

Geography Covered
• The United States
• EU5 (Germany, France, Italy, Spain and the United Kingdom)
• Japan

Study Period: 2016-2028

Allergic Conjunctivitis Epidemiology
The Allergic Conjunctivitis (AC) epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. The epidemiology data for Allergic Conjunctivitis are studied through all possible division to give a better understanding about the Disease scenario in 7MM. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Allergic Conjunctivitis Epidemiology Segmentation
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (total prevalent cases, diagnosed prevalent cases and sub-type specific prevalence) scenario of Allergic Conjunctivitis (AC) in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2016-2028.
The DelveInsight report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.
According to DelveInsight, the total number of diagnosed prevalent population of Allergic Conjunctivitis (AC) was found to be 64,945,428, in the year 2016.

Report Scope
• The report covers detailed overview of Allergic Conjunctivitis explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• The report provides the insight about the historical and forecasted patient pool of Allergic Conjunctivitis in 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Report assesses the disease risk and burden and highlights the unmet needs of the disease
• The Report helps to recognize the growth opportunities in the 7MM with respect to the patient population
• The report provides the segmentation of the disease epidemiology by sub-type i.e., Acute & Chronic Allergic Conjunctivitis in 7MM

Key strengths
• 10 Year Forecast of Allergic Conjunctivitis epidemiology
• 7MM Coverage
• Total Prevalent Cases of AC
• Prevalent Cases according to segmentation: Subtype-specific prevalence i.e., Acute & Chronic AC
• Diagnosed cases of AC

Key assessments
• Patient Segmentation
• Disease Risk & Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population

1. Key Insights
2. Disease Background and Overview: Allergic Conjunctivitis (AC)
2.1. Introduction
2.2. Classification of Allergic Conjunctivitis
2.3. Causes
2.4. Risk factors
2.5. Symptoms
2.6. Pathophysiology
2.7. Diagnosis
3. Epidemiology and Patient Population
4. Key Findings
4.1. Population and Forecast Parameters
4.2. 7MM Total Diagnosed Prevalent Patient Population of Allergic Conjunctivitis
5. Country Wise-Epidemiology of Allergic Conjunctivitis
5.1. United States
5.1.1. Total Prevalent Patient Population of Allergic Conjunctivitis in the US
5.1.2. Sub-type Specific Prevalence of Allergic Conjunctivitis in the US
5.2. EU5 Countries
5.2.1. Germany
5.2.2. Total Prevalent Patient Population of Allergic Conjunctivitis in Germany
5.2.3. Sub-type Specific Prevalence of Allergic Conjunctivitis in Germany
5.2.4. France
5.2.5. Total Prevalent Patient Population of Allergic Conjunctivitis in France
5.2.6. Sub-type Specific Prevalence of Allergic Conjunctivitis in France
5.2.7. Italy
5.2.8. Total Prevalent Patient Population of Allergic Conjunctivitis in Italy
5.2.9. Sub-type Specific Prevalence of Allergic Conjunctivitis in Italy
5.2.10. Spain
5.2.11. Total Prevalent Patient Population of Allergic Conjunctivitis in Spain
5.2.12. Sub-type Specific Prevalence of Allergic Conjunctivitis in Spain
5.2.13. United Kingdom
5.2.14. Total Prevalent Patient Population of Allergic Conjunctivitis in the UK
5.2.15. Sub-type Specific Prevalence of Allergic Conjunctivitis in the UK
5.3. Japan
5.3.1. Total Prevalent Patient Population of Allergic Conjunctivitis in Japan
5.3.2. Sub-type Specific Prevalence of Allergic Conjunctivitis in Japan
6. Unmet Needs
7. Appendix
8. Report Methodology
8.1. Sources Used
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight

LIST OF TABLES :

Table 1 Characteristics of types of AC
Table 2 Risk factors for Allergic Conjunctivitis
Table 3 Clinical involvement of the ocular tissues in allergic eye disorders
Table 4 Grading of symptoms and severity (Based on ARIA Criteria)
Table 5 Total Prevalent Patient Population of Allergic Conjunctivitis in the 7MM (2016-2028)
Table 6 Total Prevalent Population of Allergic Conjunctivitis in the United States (2016-2028)
Table 7 Sub-type Specific Prevalence of Allergic Conjunctivitis in the United States (2016-2028)
Table 8 Total Prevalent Population of Allergic Conjunctivitis in Germany (2016-2028)
Table 9 Sub-type Specific Prevalence of Allergic Conjunctivitis in Germany (2016-2028)
Table 10 Total Prevalent Population of Allergic Conjunctivitis in France (2016-2028)
Table 11 Sub-type Specific Prevalence of Allergic Conjunctivitis in France (2016-2028)
Table 12 Total Prevalent Population of Allergic Conjunctivitis in Italy (2016-2028)
Table 13 Sub-type Specific Prevalence of Allergic Conjunctivitis in Italy (2016-2028)
Table 14 Total Prevalent Population of Allergic Conjunctivitis in Spain (2016-2028)
Table 15 Sub-type Specific Prevalence of Allergic Conjunctivitis in Spain (2016-2028)
Table 16 Total Prevalent Population of Allergic Conjunctivitis in the UK (2016-2028)
Table 17 Sub-type Specific Prevalence of Allergic Conjunctivitis in the United Kingdom (2016-2028)
Table 18 Total Prevalent Population of Allergic Conjunctivitis in Japan (2016-2028)
Table 19 Sub-type Specific Prevalence of Allergic Conjunctivitis in Japan (2016-2028)

LIST OF FIGURES :

Figure 1 Characteristics of types of AC
Figure 2 Risk factors for Allergic Conjunctivitis
Figure 3 Clinical involvement of the ocular tissues in allergic eye disorders
Figure 4 Grading of symptoms and severity (Based on ARIA Criteria)
Figure 5 Total Prevalent Patient Population of Allergic Conjunctivitis in the 7MM (2016-2028)
Figure 6 Total Prevalent Population of Allergic Conjunctivitis in the United States (2016-2028)
Figure 7 Sub-type Specific Prevalence of Allergic Conjunctivitis in the United States (2016-2028)
Figure 8 Total Prevalent Population of Allergic Conjunctivitis in Germany (2016-2028)
Figure 9 Sub-type Specific Prevalence of Allergic Conjunctivitis in Germany (2016-2028)
Figure 10 Total Prevalent Population of Allergic Conjunctivitis in France (2016-2028)
Figure 11 Sub-type Specific Prevalence of Allergic Conjunctivitis in France (2016-2028)
Figure 12 Total Prevalent Population of Allergic Conjunctivitis in Italy (2016-2028)
Figure 13 Sub-type Specific Prevalence of Allergic Conjunctivitis in Italy (2016-2028)
Figure 14 Total Prevalent Population of Allergic Conjunctivitis in Spain (2016-2028)
Figure 15 Sub-type Specific Prevalence of Allergic Conjunctivitis in Spain (2016-2028)
Figure 16 Total Prevalent Population of Allergic Conjunctivitis in the UK (2016-2028)
Figure 17 Sub-type Specific Prevalence of Allergic Conjunctivitis in the United Kingdom (2016-2028)
Figure 18 Total Prevalent Population of Allergic Conjunctivitis in Japan (2016-2028)
Figure 19 Sub-type Specific Prevalence of Allergic Conjunctivitis in Japan (2016-2028)